米国のアルコール依存症治療薬市場：治療と患者の概要

U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook

発行	Frost & Sullivan
出版日	2008年01月	商品コード	59680
ページ情報	英文
価格	US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License) US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)

概要
原文目次
関連レポート

原文目次

Abstract

This research service covers the U.S. alcohol dependence and abuse pharmaceuticals market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product as follows: Antabuse, Campral, ReVia, and Vivitrol. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

1 EXECUTIVE SUMMARY

Executive Summary
- Introduction

2 TOTAL MARKET

Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Disease Overview
- Introduction
- Disease Definition
- Signs and Symptoms
- Risk Factors
- Diagnosis
- Treatment
- Health Risks of Excessive Alcohol Consumption
- Disease Statistics
Patient Outlook
- Patient Forecasts
General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints

3 MARKETED THERAPIES OVERVIEW

Overview
- Antabuse
- Campral
- ReVia
- Vivitrol

4 APPENDIX

Decision Support Databases
- Road Accident Casualties
- Liver Cancer Cases
- Total Consumption of Alcohol
- Per Capita Consumption of Alcohol
- Hypertension Prevalence